Effects of pioglitazone on cardiac and adipose tissue pathology in rats with metabolic syndrome

International Journal of Cardiology

Volumn 179, Issue , 2015, Pages 360-369

  Matsuura, Natsumi ^a   Asano, Chiharu ^b   Nagasawa, Kai ^a   Ito, Shogo ^a   Sano, Yusuke ^a   Minagawa, Yuji ^b   Yamada, Yuichiro ^a   Hattori, Takuya ^a   Watanabe, Shogo ^a   Murohara, Toyoaki ^a   Nagata, Kohzo ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY   (Japan)

Author keywords

Adipose tissue; Cardiac remodeling; Glucose metabolism; Inflammation; Metabolic syndrome; Thiazolidinedione

Indexed keywords

ADIPONECTIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; PIOGLITAZONE; THIAZOLIDINEDIONES;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDITIS; CELL ENLARGEMENT; CONTROLLED STUDY; DIASTOLIC DYSFUNCTION; DISEASE EXACERBATION; DRUG EFFECT; DRUG SAFETY; FAT MASS; FOOD INTAKE; GLUCOSE INTOLERANCE; HEART DISEASE; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE FIBROSIS; INSULIN RESISTANCE; INTRAABDOMINAL FAT; MALE; METABOLIC SYNDROME X; NONHUMAN; OBESITY; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; RAT; SUBCUTANEOUS FAT; WEIGHT GAIN; ADIPOCYTES; ANIMALS; DRUG EFFECTS; METABOLISM; MYOCARDIUM; PATHOLOGY; RATS; RATS, INBRED DAHL; RATS, ZUCKER; TREATMENT OUTCOME;

ADIPOCYTES; ADIPOSE TISSUE; ANIMALS; MALE; METABOLIC SYNDROME X; MYOCARDIUM; RATS; RATS, INBRED DAHL; RATS, ZUCKER; THIAZOLIDINEDIONES; TREATMENT OUTCOME;

EID: 84920643340     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2014.11.099     Document Type: Article

References (54)

1. M. Tiikkainen, A.M. Hakkinen, and E. Korsheninnikova Effects of rosiglitazone and metformin on liver fat content, hepatic insulin resistance, insulin clearance, and gene expression in adipose tissue in patients with type 2 diabetes Diabetes 53 2004 2169 2176
2. T. Kadowaki, and T. Yamauchi Adiponectin and adiponectin receptors Endocr. Rev. 26 2005 439 451
3. G.S. Hotamisligil, N.S. Shargill, and B.M. Spiegelman Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance Science 259 1993 87 91
4. G.S. Hotamisligil, D.L. Murray, L.N. Choy, and B.M. Spiegelman Tumor necrosis factor alpha inhibits signaling from the insulin receptor Proc. Natl. Acad. Sci. U. S. A. 91 1994 4854 4858
5. C. Hofmann, K. Lorenz, and S.S. Braithwaite Altered gene expression for tumor necrosis factor-alpha and its receptors during drug and dietary modulation of insulin resistance Endocrinology 134 1994 264 270
6. J. Berger, and D.E. Moller The mechanisms of action of PPARs Annu. Rev. Med. 53 2002 409 435
7. M. Usukura, A. Zhu, and T. Yoneda Effects of a high-salt diet on adipocyte glucocorticoid receptor and 11-beta hydroxysteroid dehydrogenase 1 in salt-sensitive hypertensive rats Steroids 74 2009 978 982
8. S. Kajimura, P. Seale, and B.M. Spiegelman Transcriptional control of brown fat development Cell Metab. 11 2010 257 262
9. H. Ohno, K. Shinoda, B.M. Spiegelman, and S. Kajimura PPARgamma agonists induce a white-to-brown fat conversion through stabilization of PRDM16 protein Cell Metab. 15 2012 395 404
10. M.F. Kato, R. Shibata, and K. Obata Pioglitazone attenuates cardiac hypertrophy in rats with salt-sensitive hypertension: role of activation of AMP-activated protein kinase and inhibition of Akt J. Hypertens. 26 2008 1669 1676
11. fa rat Nutr. Diabetes 1 2011 e1
12. fa rats: a new animal model of metabolic syndrome Hypertens. Res. 35 2012 186 193
13. 1 receptor blockade reduces cardiac calcineurin activity in hypertensive rats Hypertension 40 2002 168 174
14. D.J. Sahn, A. DeMaria, J. Kisslo, and A. Weyman Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements Circulation 58 1978 1072 1083
15. K. Nagata, M. Iwase, T. Sobue, and M. Yokota Differential effects of dobutamine and a phosphodiesterase inhibitor on early diastolic filling in patients with congestive heart failure J. Am. Coll. Cardiol. 25 1995 295 304
16. M. Miyachi, H. Yazawa, and M. Furukawa Exercise training alters left ventricular geometry and attenuates heart failure in Dahl salt-sensitive hypertensive rats Hypertension 53 2009 701 707
17. D.R. Matthews, J.P. Hosker, and A.S. Rudenski Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 1985 412 419
18. C.H. Sales, A.R. Santos, D.E. Cintra, and C. Colli Magnesium-deficient high-fat diet: effects on adiposity, lipid profile and insulin sensitivity in growing rats Clin. Nutr. 33 2013 879 888
19. K. Nagata, K. Obata, and J. Xu Mineralocorticoid receptor antagonism attenuates cardiac hypertrophy and failure in low-aldosterone hypertensive rats Hypertension 47 2006 656 664
20. A.A. Elmarakby, E.D. Loomis, J.S. Pollock, and D.M. Pollock NADPH oxidase inhibition attenuates oxidative stress but not hypertension produced by chronic ET-1 Hypertension 45 2005 283 287
21. K. Miyata, M. Rahman, and T. Shokoji Aldosterone stimulates reactive oxygen species production through activation of NADPH oxidase in rat mesangial cells J. Am. Soc. Nephrol. 16 2005 2906 2912
22. Y. Sakata, K. Yamamoto, and T. Mano Activation of matrix metalloproteinases precedes left ventricular remodeling in hypertensive heart failure rats: its inhibition as a primary effect of angiotensin-converting enzyme inhibitor Circulation 109 2004 2143 2149
23. fa rats as a new animal model of metabolic syndrome Hypertension 59 2012 694 704
24. T. Yamada, K. Nagata, and X.W. Cheng Long-term administration of nifedipine attenuates cardiac remodeling and diastolic heart failure in hypertensive rats Eur. J. Pharmacol. 615 2009 163 170
25. J. Xu, K. Nagata, and K. Obata Nicorandil promotes myocardial capillary and arteriolar growth in the failing heart of Dahl salt-sensitive hypertensive rats Hypertension 46 2005 719 724
26. M.S. Ahmed, E. Oie, and L.E. Vinge Connective tissue growth factor - a novel mediator of angiotensin II-stimulated cardiac fibroblast activation in heart failure in rats J. Mol. Cell. Cardiol. 36 2004 393 404
27. Y. Saitoh, R. Liu, H. Ueno, M. Mizuta, and M. Nakazato Oral pioglitazone administration increases food intake through ghrelin-independent pathway in Zucker fatty rat Diabetes Res. Clin. Pract. 77 2007 351 356
28. S. Dryden, H. Frankish, Q. Wang, and G. Williams Neuropeptide Y and energy balance: one way ahead for the treatment of obesity? Eur. J. Clin. Invest. 24 1994 293 308
29. M.W. Schwartz, D.P. Figlewicz, D.G. Baskin, S.C. Woods, and D. Porte Jr. Insulin in the brain: a hormonal regulator of energy balance Endocr. Rev. 13 1992 387 414
30. A.M. Strack, R.J. Sebastian, M.W. Schwartz, and M.F. Dallman Glucocorticoids and insulin: reciprocal signals for energy balance Am. J. Physiol. 268 1995 R142 R149
31. F. Dentali, A. Squizzato, and W. Ageno The metabolic syndrome as a risk factor for venous and arterial thrombosis Semin. Thromb. Hemost. 35 2009 451 457
32. K. Takahashi, S. Mizuarai, and H. Araki Adiposity elevates plasma MCP-1 levels leading to the increased CD11b-positive monocytes in mice J. Biol. Chem. 278 2003 46654 46660
33. H. Shi, M.V. Kokoeva, and K. Inouye TLR4 links innate immunity and fatty acid-induced insulin resistance J. Clin. Invest. 116 2006 3015 3025
34. A. Okuno, H. Tamemoto, and K. Tobe Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats J. Clin. Invest. 101 1998 1354 1361
35. S. Hallakou, L. Doare, and F. Foufelle Pioglitazone induces in vivo adipocyte differentiation in the obese Zucker fa/fa rat Diabetes 46 1997 1393 1399
36. P. Zhang, X. Hu, and X. Xu AMP activated protein kinase-alpha2 deficiency exacerbates pressure-overload-induced left ventricular hypertrophy and dysfunction in mice Hypertension 52 2008 918 924
37. D. Fujioka, K. Kawabata, and Y. Saito Role of adiponectin receptors in endothelin-induced cellular hypertrophy in cultured cardiomyocytes and their expression in infarcted heart Am. J. Physiol. Heart Circ. Physiol. 290 2006 H2409 H2416
38. R. Shibata, N. Ouchi, and T. Murohara Adiponectin and cardiovascular disease Circ. J. 73 2009 608 614
39. Y. Minokoshi, T. Alquier, and N. Furukawa AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus Nature 428 2004 569 574
40. A. Kudoh, H. Satoh, H. Hirai, and T. Watanabe Pioglitazone upregulates adiponectin receptor 2 in 3T3-L1 adipocytes Life Sci. 88 2011 1055 1062
41. N.K. LeBrasseur, M. Kelly, and T.S. Tsao Thiazolidinediones can rapidly activate AMP-activated protein kinase in mammalian tissues Am. J. Physiol. Endocrinol. Metab. 291 2006 E175 E181
42. S. Horman, D. Vertommen, and R. Heath Insulin antagonizes ischemia-induced Thr172 phosphorylation of AMP-activated protein kinase alpha-subunits in heart via hierarchical phosphorylation of Ser485/491 J. Biol. Chem. 281 2006 5335 5340
43. N. Rasouli, P.A. Kern, S.C. Elbein, N.K. Sharma, and S.K. Das Improved insulin sensitivity after treatment with PPARgamma and PPARalpha ligands is mediated by genetically modulated transcripts Pharmacogenet. Genomics 22 2012 484 497
44. F. Oana, H. Takeda, and K. Hayakawa Physiological difference between obese (fa/fa) Zucker rats and lean Zucker rats concerning adiponectin Metabolism 54 2005 995 1001
45. T.A. Hopkins, N. Ouchi, R. Shibata, and K. Walsh Adiponectin actions in the cardiovascular system Cardiovasc. Res. 74 2007 11 18
46. P.A. Permana, W. Zhang, and M. Wabitsch Pioglitazone reduces inflammatory responses of human adipocytes to factors secreted by monocytes/macrophages Am. J. Physiol. Endocrinol. Metab. 296 2009 E1076 E1084
47. S. Furukawa, T. Fujita, and M. Shimabukuro Increased oxidative stress in obesity and its impact on metabolic syndrome J. Clin. Invest. 114 2004 1752 1761
48. C.M. Boustany, K. Bharadwaj, and A. Daugherty Activation of the systemic and adipose renin-angiotensin system in rats with diet-induced obesity and hypertension Am. J. Physiol. Regul. Integr. Comp. Physiol. 287 2004 R943 R949
49. C.A. Staab, and E. Maser 11beta-Hydroxysteroid dehydrogenase type 1 is an important regulator at the interface of obesity and inflammation J. Steroid Biochem. Mol. Biol. 119 2010 56 72
50. A.J. Rose, A. Vegiopoulos, and S. Herzig Role of glucocorticoids and the glucocorticoid receptor in metabolism: insights from genetic manipulations J. Steroid Biochem. Mol. Biol. 122 2010 10 20
51. A.M. Samuelsson, E. Bollano, and R. Mobini Hyperinsulinemia: effect on cardiac mass/function, angiotensin II receptor expression, and insulin signaling pathways Am. J. Physiol. Heart Circ. Physiol. 291 2006 H787 H796
52. P.D. Miles, O.M. Romeo, and K. Higo TNF-alpha-induced insulin resistance in vivo and its prevention by troglitazone Diabetes 46 1997 1678 1683
53. P. Peraldi, M. Xu, and B.M. Spiegelman Thiazolidinediones block tumor necrosis factor-alpha-induced inhibition of insulin signaling J. Clin. Invest. 100 1997 1863 1869
54. Y. Guan, C. Hao, and D.R. Cha Thiazolidinediones expand body fluid volume through PPARgamma stimulation of ENaC-mediated renal salt absorption Nat. Med. 11 2005 861 866